Parkinson Disease

Sensor Array May Detect De Novo Parkinson's Disease in Breath

Sensor Array May Detect De Novo Parkinson's Disease in Breath

A sensor array has the potential to identify de novo Parkinson's disease (PD) patients with high sensitivity, specificity, and accuracy values.

Repetitive TMS for Parkinson Disease Depression Non-Superior to SSRI Therapy

Repetitive TMS for Parkinson Disease Depression Non-Superior to SSRI Therapy

By

The studies that included neurocognitive measures demonstrated no significant difference between the use of rTMS and sham-rTMS.

<i>LRP10</i> Gene Variants Implicated in Parkinson Disease, Lewy Body Dementia

LRP10 Gene Variants Implicated in Parkinson Disease, Lewy Body Dementia

By

Mutations in the LRP10 gene appear to be common in patients with inherited α-synucleinopathies.

Changes in Glucose Regulation in Parkinson Disease

Changes in Glucose Regulation in Parkinson Disease

By

Investigators sought to determine whether patients with moderate to advanced Parkinson disease have impaired glucose levels during an Oral Glucose Tolerance Test.

FDA Approves New Pimavanserin Formulation, Dosage Strength

FDA Approves New Pimavanserin Formulation, Dosage Strength

By

Nuplazid, a non-dopaminergic, selective serotonin inverse agonist, targets 5-HT2A receptors that are thought to be involved in Parkinson's disease psychosis.

Enhanced Scale Helps Accurately Identify Psychotic Symptoms in Parkinson Disease

Enhanced Scale Helps Accurately Identify Psychotic Symptoms in Parkinson Disease

By

Using information from these assessments, investigators identified participants as having either major psychotic symptoms, isolated minor psychotic symptoms, or no psychotic symptoms.

Predictive Tool May Be Effective for Identifying Dementia Risk in Parkinson Disease

Predictive Tool May Be Effective for Identifying Dementia Risk in Parkinson Disease

By

Researchers conducted a multicenter study to assess the predictive value of the Montreal Parkinson Risk of Dementia Scale, an 8-item, office-based screening tool.

Prognostic Significance of Weight Loss in Patients With Early Parkinsonism

Prognostic Significance of Weight Loss in Patients With Early Parkinsonism

By

Investigators analyzed data for baseline factors that may influence weight loss in early parkinson's disease.

Sign Up for Free e-newsletters



CME Focus